Monday, 20 December 2010

Hyalein Mini




Hyalein Mini may be available in the countries listed below.


Ingredient matches for Hyalein Mini



Hyaluronic Acid

Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Hyalein Mini in the following countries:


  • Japan

International Drug Name Search

Saturday, 18 December 2010

Servambutol




Servambutol may be available in the countries listed below.


Ingredient matches for Servambutol



Ethambutol

Ethambutol is reported as an ingredient of Servambutol in the following countries:


  • Peru

Ethambutol dihydrochloride (a derivative of Ethambutol) is reported as an ingredient of Servambutol in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 16 December 2010

Kitex




Kitex may be available in the countries listed below.


Ingredient matches for Kitex



Ketoprofen

Ketoprofen is reported as an ingredient of Kitex in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday, 14 December 2010

MG 217




Ingredient matches for MG 217



Salicylic Acid

Salicylic Acid is reported as an ingredient of MG 217 in the following countries:


  • United States

International Drug Name Search

Saturday, 11 December 2010

Scaper




Scaper may be available in the countries listed below.


Ingredient matches for Scaper



Permethrin

Permethrin is reported as an ingredient of Scaper in the following countries:


  • Bangladesh

International Drug Name Search

Cetrizen




Cetrizen may be available in the countries listed below.


Ingredient matches for Cetrizen



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetrizen in the following countries:


  • Poland

International Drug Name Search

Saturday, 4 December 2010

Facteur Von Willebrandt




Facteur Von Willebrandt may be available in the countries listed below.


Ingredient matches for Facteur Von Willebrandt



Von Willebrand Factor, Human

Von Willebrand Factor, Human is reported as an ingredient of Facteur Von Willebrandt in the following countries:


  • Luxembourg

International Drug Name Search

Thursday, 2 December 2010

Pedrox




Pedrox may be available in the countries listed below.


Ingredient matches for Pedrox



Roxithromycin

Roxithromycin is reported as an ingredient of Pedrox in the following countries:


  • Bangladesh

International Drug Name Search

Friday, 26 November 2010

Eukaptil




Eukaptil may be available in the countries listed below.


Ingredient matches for Eukaptil



Captopril

Captopril is reported as an ingredient of Eukaptil in the following countries:


  • Serbia

International Drug Name Search

Tuesday, 23 November 2010

Omeprazol Reddypharma




Omeprazol Reddypharma may be available in the countries listed below.


Ingredient matches for Omeprazol Reddypharma



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Reddypharma in the following countries:


  • Spain

International Drug Name Search

Sunday, 21 November 2010

Pirazinamida Veinfar




Pirazinamida Veinfar may be available in the countries listed below.


Ingredient matches for Pirazinamida Veinfar



Pyrazinamide

Pyrazinamide is reported as an ingredient of Pirazinamida Veinfar in the following countries:


  • Argentina

International Drug Name Search

Saturday, 20 November 2010

Liotironina Sodica L.CH.




Liotironina Sodica L.CH. may be available in the countries listed below.


Ingredient matches for Liotironina Sodica L.CH.



Liothyronine

Liothyronine sodium salt (a derivative of Liothyronine) is reported as an ingredient of Liotironina Sodica L.CH. in the following countries:


  • Chile

International Drug Name Search

Bodrex forte




Bodrex forte may be available in the countries listed below.


Ingredient matches for Bodrex forte



Paracetamol

Paracetamol is reported as an ingredient of Bodrex forte in the following countries:


  • Indonesia

International Drug Name Search

Monday, 15 November 2010

Biolanz




Biolanz may be available in the countries listed below.


Ingredient matches for Biolanz



Lansoprazole

Lansoprazole is reported as an ingredient of Biolanz in the following countries:


  • Venezuela

International Drug Name Search

Sunday, 14 November 2010

Teledol




Teledol may be available in the countries listed below.


Ingredient matches for Teledol



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Teledol in the following countries:


  • Argentina

International Drug Name Search

Saturday, 13 November 2010

Flunitrazepam Sandoz




Flunitrazepam Sandoz may be available in the countries listed below.


Ingredient matches for Flunitrazepam Sandoz



Flunitrazepam

Flunitrazepam is reported as an ingredient of Flunitrazepam Sandoz in the following countries:


  • Netherlands

International Drug Name Search

Thursday, 11 November 2010

Colo-Pleon




Colo-Pleon may be available in the countries listed below.


Ingredient matches for Colo-Pleon



Sulfasalazine

Sulfasalazine is reported as an ingredient of Colo-Pleon in the following countries:


  • Germany

International Drug Name Search

Wednesday, 10 November 2010

TilactaMed




TilactaMed may be available in the countries listed below.


Ingredient matches for TilactaMed



Tilactase

Tilactase is reported as an ingredient of TilactaMed in the following countries:


  • Germany

International Drug Name Search

Sunday, 7 November 2010

Gabapentina Cinfa




Gabapentina Cinfa may be available in the countries listed below.


Ingredient matches for Gabapentina Cinfa



Gabapentin

Gabapentin is reported as an ingredient of Gabapentina Cinfa in the following countries:


  • Spain

International Drug Name Search

Friday, 5 November 2010

Biofenac Gotas




Biofenac Gotas may be available in the countries listed below.


Ingredient matches for Biofenac Gotas



Diclofenac

Diclofenac resinate (a derivative of Diclofenac) is reported as an ingredient of Biofenac Gotas in the following countries:


  • Brazil

International Drug Name Search

Thursday, 4 November 2010

Selbex




Selbex may be available in the countries listed below.


Ingredient matches for Selbex



Teprenone

Teprenone is reported as an ingredient of Selbex in the following countries:


  • China

  • Dominican Republic

  • El Salvador

  • Japan

  • Myanmar

  • Philippines

  • Thailand

  • Vietnam

International Drug Name Search

Wednesday, 3 November 2010

Alendronato Genfar




Alendronato Genfar may be available in the countries listed below.


Ingredient matches for Alendronato Genfar



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronato Genfar in the following countries:


  • Chile

  • Colombia

  • Ecuador

International Drug Name Search

Thursday, 28 October 2010

E-Zentius




E-Zentius may be available in the countries listed below.


Ingredient matches for E-Zentius



Escitalopram

Escitalopram oxalate (a derivative of Escitalopram) is reported as an ingredient of E-Zentius in the following countries:


  • Peru

International Drug Name Search

Wednesday, 20 October 2010

PA Iodo




PA Iodo may be available in the countries listed below.


Ingredient matches for PA Iodo



Iodine

Iodine is reported as an ingredient of PA Iodo in the following countries:


  • Japan

International Drug Name Search

Monday, 18 October 2010

Orudis Topico




Orudis Topico may be available in the countries listed below.


Ingredient matches for Orudis Topico



Ketoprofen

Ketoprofen is reported as an ingredient of Orudis Topico in the following countries:


  • Spain

International Drug Name Search

Saturday, 16 October 2010

Gram Negative Infection Medications


Drugs associated with Gram Negative Infection

The following drugs and medications are in some way related to, or used in the treatment of Gram Negative Infection. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

Friday, 15 October 2010

Carbomère




Carbomère may be available in the countries listed below.


Ingredient matches for Carbomère



Carbomer

Carbomère (DCF) is also known as Carbomer (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Loratadine Apotex




Loratadine Apotex may be available in the countries listed below.


Ingredient matches for Loratadine Apotex



Loratadine

Loratadine is reported as an ingredient of Loratadine Apotex in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, 12 October 2010

Venlafaxin-Actavis




Venlafaxin-Actavis may be available in the countries listed below.


Ingredient matches for Venlafaxin-Actavis



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Venlafaxin-Actavis in the following countries:


  • Austria

  • Germany

  • Sweden

  • Switzerland

International Drug Name Search

Monday, 11 October 2010

Atracurio




Atracurio may be available in the countries listed below.


Ingredient matches for Atracurio



Atracurium Besilate

Atracurium Besilate is reported as an ingredient of Atracurio in the following countries:


  • Peru

International Drug Name Search

Friday, 8 October 2010

Naloxone HCl-Fresenius




Naloxone HCl-Fresenius may be available in the countries listed below.


Ingredient matches for Naloxone HCl-Fresenius



Naloxone

Naloxone hydrochloride (a derivative of Naloxone) is reported as an ingredient of Naloxone HCl-Fresenius in the following countries:


  • South Africa

International Drug Name Search

Thursday, 7 October 2010

Fentanyl Richter




Fentanyl Richter may be available in the countries listed below.


Ingredient matches for Fentanyl Richter



Fentanyl

Fentanyl is reported as an ingredient of Fentanyl Richter in the following countries:


  • Bulgaria

  • Estonia

International Drug Name Search

Wednesday, 6 October 2010

Tapering Regimen Medications


There are currently no drugs listed for "Tapering Regimen".





Drug List:

Tuesday, 5 October 2010

Ortho Micronor




In the US, Ortho Micronor (norethindrone systemic) is a member of the following drug classes: contraceptives, progestins and is used to treat Abnormal Uterine Bleeding, Amenorrhea, Birth Control and Endometriosis.

US matches:

  • Ortho Micronor

Ingredient matches for Ortho Micronor



Norethisterone

Norethisterone is reported as an ingredient of Ortho Micronor in the following countries:


  • United States

International Drug Name Search

Adolor




Adolor may be available in the countries listed below.


Ingredient matches for Adolor



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Adolor in the following countries:


  • Russian Federation

International Drug Name Search

Saturday, 2 October 2010

Apo-Lactulose




Apo-Lactulose may be available in the countries listed below.


Ingredient matches for Apo-Lactulose



Lactulose

Lactulose is reported as an ingredient of Apo-Lactulose in the following countries:


  • Canada

International Drug Name Search

Rectiv


Rectiv is a brand name of nitroglycerin, approved by the FDA in the following formulation(s):


RECTIV (nitroglycerin - ointment; intra-anal)



  • Manufacturer: APTALIS PHARMA

    Approval date: June 21, 2011

    Strength(s): 0.4% [RLD]

Has a generic version of Rectiv been approved?


No. There is currently no therapeutically equivalent version of Rectiv available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rectiv. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Nitric oxide donor composition and method for treatment of anal disorders
    Patent 7,189,761
    Issued: March 13, 2007
    Inventor(s): Gorfine; Stephen R.
    A pharmaceutical composition contains a nitric oxide donor and advantageously an optional corticosteroid and/or topical anesthetic. The composition is useful in a method for treating anal disorders such as anal fissure, anal ulcer, hemorrhoidal disease, levator spasm, and so forth, by topical application to or proximate the affected area.
    Patent expiration dates:

    • May 27, 2014
      ✓ 
      Patent use: RECTIV IS A NITRATE VASODILATOR INDICATED FOR THE TREATMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH CHRONIC ANAL FISSURE
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • June 21, 2014 - NEW PRODUCT

See also...

  • Rectiv Consumer Information (Drugs.com)
  • Nitroglycerin Consumer Information (Wolters Kluwer)
  • Nitroglycerin Aerosol Consumer Information (Wolters Kluwer)
  • Nitroglycerin Controlled-Release Capsules Consumer Information (Wolters Kluwer)
  • Nitroglycerin Ointment Consumer Information (Wolters Kluwer)
  • Nitroglycerin Patch Consumer Information (Wolters Kluwer)
  • Nitroglycerin Spray Consumer Information (Wolters Kluwer)
  • Nitroglycerin Tablets Consumer Information (Wolters Kluwer)
  • Nitroglycerin oral/sublingual Consumer Information (Cerner Multum)
  • Nitroglycerin topical Consumer Information (Cerner Multum)
  • Nitroglycerin transdermal Consumer Information (Cerner Multum)
  • Gen-Nitro Advanced Consumer Information (Micromedex)
  • Nitrotab Advanced Consumer Information (Micromedex)
  • Trinipatch 0.2 Advanced Consumer Information (Micromedex)
  • Trinipatch 0.4 Advanced Consumer Information (Micromedex)
  • Trinipatch 0.6 Advanced Consumer Information (Micromedex)
  • Nitroglycerin Intravenous Advanced Consumer Information (Micromedex)
  • Nitroglycerin Oral, Sublingual Advanced Consumer Information (Micromedex)
  • Nitroglycerin Transdermal Advanced Consumer Information (Micromedex)
  • Nitroglycerin AHFS DI Monographs (ASHP)

Tuesday, 28 September 2010

Mapin




Mapin may be available in the countries listed below.


Ingredient matches for Mapin



Naloxone

Naloxone hydrochloride (a derivative of Naloxone) is reported as an ingredient of Mapin in the following countries:


  • Bangladesh

  • Hong Kong

International Drug Name Search

Biotrim Balsámico




Biotrim Balsámico may be available in the countries listed below.


Ingredient matches for Biotrim Balsámico



Guaifenesin

Guaifenesin is reported as an ingredient of Biotrim Balsámico in the following countries:


  • Peru

Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Biotrim Balsámico in the following countries:


  • Peru

Trimethoprim

Trimethoprim is reported as an ingredient of Biotrim Balsámico in the following countries:


  • Peru

International Drug Name Search

Monday, 27 September 2010

Fenoverina




Fenoverina may be available in the countries listed below.


Ingredient matches for Fenoverina



Fenoverine

Fenoverina (DCIT) is also known as Fenoverine (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Utabon




Utabon may be available in the countries listed below.


Ingredient matches for Utabon



Oxymetazoline

Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Utabon in the following countries:


  • Costa Rica

  • El Salvador

  • Guatemala

  • Honduras

  • Malta

  • Nicaragua

  • Panama

  • Spain

International Drug Name Search

Saturday, 25 September 2010

Cefpodoxim-dura




Cefpodoxim-dura may be available in the countries listed below.


Ingredient matches for Cefpodoxim-dura



Cefpodoxime

Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Cefpodoxim-dura in the following countries:


  • Germany

International Drug Name Search

Monday, 20 September 2010

Arnela




Arnela may be available in the countries listed below.


Ingredient matches for Arnela



Clotrimazole

Clotrimazole is reported as an ingredient of Arnela in the following countries:


  • Chile

International Drug Name Search

Saturday, 18 September 2010

Baydol




Baydol may be available in the countries listed below.


Ingredient matches for Baydol



Acemetacin

Acemetacin is reported as an ingredient of Baydol in the following countries:


  • Colombia

International Drug Name Search

Tuesday, 14 September 2010

Clordiazepossido




Clordiazepossido may be available in the countries listed below.


Ingredient matches for Clordiazepossido



Chlordiazepoxide

Clordiazepossido (DCIT) is known as Chlordiazepoxide in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 11 September 2010

Citabax




Citabax may be available in the countries listed below.


Ingredient matches for Citabax



Ciclosporin

Ciclosporin is reported as an ingredient of Citabax in the following countries:


  • Poland

International Drug Name Search

Friday, 27 August 2010

Actalipid




Actalipid may be available in the countries listed below.


Ingredient matches for Actalipid



Simvastatin

Simvastatin is reported as an ingredient of Actalipid in the following countries:


  • Bulgaria

  • Georgia

  • Russian Federation

  • Slovenia

International Drug Name Search

Logican




Logican may be available in the countries listed below.


Ingredient matches for Logican



Fluconazole

Fluconazole is reported as an ingredient of Logican in the following countries:


  • India

International Drug Name Search

Tuesday, 24 August 2010

Biodylon




Biodylon may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Biodylon



Mesulfen

Mesulfen is reported as an ingredient of Biodylon in the following countries:


  • Poland

International Drug Name Search

Saturday, 21 August 2010

Hitagen




Hitagen may be available in the countries listed below.


Ingredient matches for Hitagen



Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Hitagen in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 19 August 2010

Actiblok-IPR




Actiblok-IPR may be available in the countries listed below.


Ingredient matches for Actiblok-IPR



Metoprolol

Metoprolol succinate (a derivative of Metoprolol) is reported as an ingredient of Actiblok-IPR in the following countries:


  • India

International Drug Name Search

Wednesday, 18 August 2010

Kyopinal




Kyopinal may be available in the countries listed below.


Ingredient matches for Kyopinal



Alclofenac

Alclofenac is reported as an ingredient of Kyopinal in the following countries:


  • Taiwan

International Drug Name Search

Monday, 16 August 2010

Ufocollyre




Ufocollyre may be available in the countries listed below.


Ingredient matches for Ufocollyre



Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Ufocollyre in the following countries:


  • Greece

International Drug Name Search

Muvito




Muvito may be available in the countries listed below.


Ingredient matches for Muvito



Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Muvito in the following countries:


  • Greece

International Drug Name Search

Thursday, 12 August 2010

Ciprofloxacino Acost




Ciprofloxacino Acost may be available in the countries listed below.


Ingredient matches for Ciprofloxacino Acost



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprofloxacino Acost in the following countries:


  • Spain

International Drug Name Search

Dial




Dial may be available in the countries listed below.


Ingredient matches for Dial



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Dial in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, 8 August 2010

Hibisoft




Hibisoft may be available in the countries listed below.


Ingredient matches for Hibisoft



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Hibisoft in the following countries:


  • Japan

International Drug Name Search

Saturday, 7 August 2010

Becetamol




Becetamol may be available in the countries listed below.


Ingredient matches for Becetamol



Paracetamol

Paracetamol is reported as an ingredient of Becetamol in the following countries:


  • Switzerland

International Drug Name Search

Sunday, 1 August 2010

Nilac




Nilac may be available in the countries listed below.


Ingredient matches for Nilac



Tretinoin

Tretinoin is reported as an ingredient of Nilac in the following countries:


  • Bangladesh

International Drug Name Search

Fluciderm




Fluciderm may be available in the countries listed below.


Ingredient matches for Fluciderm



Fluocinolone

Fluocinolone Acetonide is reported as an ingredient of Fluciderm in the following countries:


  • Ethiopia

  • Sri Lanka

International Drug Name Search

GenRX Fluoxetine




GenRX Fluoxetine may be available in the countries listed below.


Ingredient matches for GenRX Fluoxetine



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of GenRX Fluoxetine in the following countries:


  • Australia

International Drug Name Search

Tuesday, 27 July 2010

Idovit




Idovit may be available in the countries listed below.


Ingredient matches for Idovit



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Idovit in the following countries:


  • Israel

International Drug Name Search

Thursday, 22 July 2010

Insulina Isofana Humana Recombinante




Insulina Isofana Humana Recombinante may be available in the countries listed below.


Ingredient matches for Insulina Isofana Humana Recombinante



Insulin, Isophane

Insulin, Isophane human (a derivative of Insulin, Isophane) is reported as an ingredient of Insulina Isofana Humana Recombinante in the following countries:


  • Peru

International Drug Name Search

Tuesday, 20 July 2010

Oxiconazole Cream


Pronunciation: ox-ee-KON-uh-zole
Generic Name: Oxiconazole
Brand Name: Oxistat


Oxiconazole Cream is used for:

Treating fungal infections, such as athlete's foot, jock itch, and ringworm. It may also be used for other conditions as determined by your doctor.


Oxiconazole Cream is an antifungal. It works by killing or preventing the growth of the fungus.


Do NOT use Oxiconazole Cream if:


  • you are allergic to any ingredient in Oxiconazole Cream

  • you are taking astemizole or terfenadine

Contact your doctor or health care provider right away if any of these apply to you.



Before using Oxiconazole Cream:


Some medical conditions may interact with Oxiconazole Cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

Some MEDICINES MAY INTERACT with Oxiconazole Cream. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Anticoagulants (eg, warfarin), H1 antagonists (eg, astemizole, terfenadine), or sulfonylureas (eg, glyburide) because their actions and the risk of their side effects may be increased by Oxiconazole Cream

This may not be a complete list of all interactions that may occur. Ask your health care provider if Oxiconazole Cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Oxiconazole Cream:


Use Oxiconazole Cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Oxiconazole Cream is for external use only. Avoid contact with the eyes, nose, mouth, genital area, and other mucous membranes.

  • Clean the affected area with soap and water and dry thoroughly.

  • Apply enough medicine to cover the affected area. Rub in gently.

  • Do not cover area with bandages or other occlusive dressings unless directed otherwise by your doctor.

  • Wash your hands immediately after using Oxiconazole Cream, unless your hands are a part of the treated area.

  • To clear up your infection completely, use Oxiconazole Cream for the full course of treatment. Keep using it even if you feel better in a few days.

  • If you miss a dose of Oxiconazole Cream and you are using it regularly, use it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Oxiconazole Cream.



Important safety information:


  • Be sure to use Oxiconazole Cream for the full course of treatment. If you do not, the medicine may not clear up your infection completely. The fungus could also become less sensitive to this or other medicines. This could make the infection harder to treat in the future.

  • If your symptoms do not get better within 2 to 4 weeks or if they get worse, check with your doctor.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Oxiconazole Cream while you are pregnant. Oxiconazole Cream is found in breast milk. Do not breast-feed while taking Oxiconazole Cream.


Possible side effects of Oxiconazole Cream:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Mild stinging.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); nodules; reddening, blistering, peeling, itching, or burning of skin; scaling; skin cracking; swelling of the hair follicles.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Oxiconazole side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Oxiconazole Cream may be harmful if swallowed.


Proper storage of Oxiconazole Cream:

Store Oxiconazole Cream between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, light, and moisture. Keep Oxiconazole Cream out of the reach of children and away from pets.


General information:


  • If you have any questions about Oxiconazole Cream, please talk with your doctor, pharmacist, or other health care provider.

  • Oxiconazole Cream is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Oxiconazole Cream. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Oxiconazole resources


  • Oxiconazole Side Effects (in more detail)
  • Oxiconazole Dosage
  • Oxiconazole Use in Pregnancy & Breastfeeding
  • Oxiconazole Support Group
  • 2 Reviews for Oxiconazole - Add your own review/rating


Compare Oxiconazole with other medications


  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis
  • Tinea Versicolor

Sunday, 18 July 2010

Pharmaniaga Methyldopa




Pharmaniaga Methyldopa may be available in the countries listed below.


Ingredient matches for Pharmaniaga Methyldopa



Methyldopa

Methyldopa is reported as an ingredient of Pharmaniaga Methyldopa in the following countries:


  • Malaysia

International Drug Name Search

Saturday, 17 July 2010

Eifel




Eifel may be available in the countries listed below.


Ingredient matches for Eifel



Betaxolol

Betaxolol hydrochloride (a derivative of Betaxolol) is reported as an ingredient of Eifel in the following countries:


  • Greece

International Drug Name Search

Friday, 16 July 2010

Foziretic




Foziretic may be available in the countries listed below.


Ingredient matches for Foziretic



Fosinopril

Fosinopril sodium salt (a derivative of Fosinopril) is reported as an ingredient of Foziretic in the following countries:


  • France

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Foziretic in the following countries:


  • France

International Drug Name Search

Wednesday, 7 July 2010

Metformin-Puren




Metformin-Puren may be available in the countries listed below.


Ingredient matches for Metformin-Puren



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformin-Puren in the following countries:


  • Germany

International Drug Name Search

Tuesday, 6 July 2010

Vitalene E




Vitalene E may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vitalene E



Tocopherol, α-

Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Vitalene E in the following countries:


  • Italy

International Drug Name Search

Sunday, 4 July 2010

Be-Oxytet




Be-Oxytet may be available in the countries listed below.


Ingredient matches for Be-Oxytet



Oxytetracycline

Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Be-Oxytet in the following countries:


  • South Africa

International Drug Name Search

Saturday, 3 July 2010

Ecofluke




Ecofluke may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ecofluke



Triclabendazole

Triclabendazole is reported as an ingredient of Ecofluke in the following countries:


  • South Africa

International Drug Name Search

Thursday, 1 July 2010

Ramipril Galex




Ramipril Galex may be available in the countries listed below.


Ingredient matches for Ramipril Galex



Ramipril

Ramipril is reported as an ingredient of Ramipril Galex in the following countries:


  • Slovenia

International Drug Name Search

Friday, 25 June 2010

Azathioprin dura




Azathioprin dura may be available in the countries listed below.


Ingredient matches for Azathioprin dura



Azathioprine

Azathioprine is reported as an ingredient of Azathioprin dura in the following countries:


  • Germany

International Drug Name Search

Wednesday, 23 June 2010

Elleogest




Elleogest may be available in the countries listed below.


Ingredient matches for Elleogest



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Elleogest in the following countries:


  • Switzerland

Gestodene

Gestodene is reported as an ingredient of Elleogest in the following countries:


  • Switzerland

International Drug Name Search

Sunday, 20 June 2010

Beeone




Beeone may be available in the countries listed below.


Ingredient matches for Beeone



Thiamine

Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Beeone in the following countries:


  • Japan

International Drug Name Search

Saturday, 19 June 2010

Flamind




Flamind may be available in the countries listed below.


Ingredient matches for Flamind



Indinavir

Indinavir is reported as an ingredient of Flamind in the following countries:


  • Ethiopia

International Drug Name Search

Friday, 18 June 2010

Beclod




Beclod may be available in the countries listed below.


Ingredient matches for Beclod



Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Beclod in the following countries:


  • Bangladesh

International Drug Name Search

Cetriwal




Cetriwal may be available in the countries listed below.


Ingredient matches for Cetriwal



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetriwal in the following countries:


  • India

International Drug Name Search

Sunday, 13 June 2010

Edex




In the US, Edex (alprostadil systemic) is a member of the following drug classes: impotence agents, vasodilators and is used to treat Erectile Dysfunction.

US matches:

  • Edex

  • Edex injectable and transurethral

Ingredient matches for Edex



Alprostadil

Alprostadil is reported as an ingredient of Edex in the following countries:


  • France

  • United States

International Drug Name Search

Friday, 11 June 2010

Calci Top




Calci Top may be available in the countries listed below.


Ingredient matches for Calci Top



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Calci Top in the following countries:


  • Oman

Calcium Lactobionate

Calcium Lactobionate is reported as an ingredient of Calci Top in the following countries:


  • Oman

International Drug Name Search

Dela




Dela may be available in the countries listed below.


Ingredient matches for Dela



Gliclazide

Gliclazide is reported as an ingredient of Dela in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 3 June 2010

Cortavance




Cortavance may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cortavance



Hydrocortisone

Hydrocortisone aceponate (a derivative of Hydrocortisone) is reported as an ingredient of Cortavance in the following countries:


  • Australia

  • Austria

  • Finland

  • France

  • Germany

  • New Zealand

  • Switzerland

International Drug Name Search

Bialcol




Bialcol may be available in the countries listed below.


Ingredient matches for Bialcol



Benzoxonium Chloride

Benzoxonium Chloride is reported as an ingredient of Bialcol in the following countries:


  • Chile

  • Italy

International Drug Name Search

Tuesday, 1 June 2010

Nasic




Nasic may be available in the countries listed below.


Ingredient matches for Nasic



Dexpanthenol

Dexpanthenol is reported as an ingredient of Nasic in the following countries:


  • Germany

  • Switzerland

Xylometazoline

Xylometazoline hydrochloride (a derivative of Xylometazoline) is reported as an ingredient of Nasic in the following countries:


  • Germany

  • Switzerland

International Drug Name Search

Wednesday, 26 May 2010

rocuronium


Generic Name: rocuronium (ROE kure OH nee um)

Brand Names: Zemuron


What is rocuronium?

Rocuronium is used to relax the muscles. It works by blocking the signals between your nerves and your muscles.


Rocuronium is given before general anesthesia in preparing you for surgery. Rocuronium helps keep your body still during surgery. It also relaxes your throat so a breathing tube can be more easily inserted before the surgery.


Rocuronium may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about rocuronium?


Before receiving rocuronium, tell your doctor if you have myasthenia gravis, cirrhosis or other liver disease, a history of kidney disease, heart disease, a history of "Long QT Syndrome," problems with circulation, or if you have ever had an allergic reaction to another anesthetic medication.


Before you receive rocuronium, tell your doctor if you are pregnant or breast-feeding.


There may be other drugs that can interact with rocuronium, especially seizure medication, certain antibiotics, lithium, procainamide, or magnesium. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors.


It may take you longer to recover from the effects of rocuronium if you have cirrhosis or other liver disease.


Follow your doctor's instructions about any restrictions on food, beverages, or activity after you recover from anesthesia.


What should I discuss with my health care provider before receiving rocuronium?


You should not receive this medication if you are allergic to rocuronium.

If you have certain conditions, you may need a dose adjustment or special care to safely receive this medication. Before you receive rocuronium, tell your doctor if you have:



  • myasthenia gravis;




  • cirrhosis or other liver disease;




  • a history of kidney disease;




  • heart disease;




  • a history of "Long QT Syndrome";




  • problems with circulation; or




  • if you have ever had an allergic reaction to another anesthetic medication.




FDA pregnancy category C. It is not known whether rocuronium is harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether rocuronium passes into breast milk or if it could harm a nursing baby. Before receiving rocuronium, tell your doctor if you are breast-feeding a baby.

How is rocuronium given?


Rocuronium is given as an injection through a needle placed into a vein. You will receive this injection in a hospital or surgical setting.


Your caregivers will monitor your heart function, blood pressure, and breathing while you are under the effects of rocuronium.


It may take you longer to recover from the effects of rocuronium if you have cirrhosis or other liver disease.


What happens if I miss a dose?


Since rocuronium is usually given just for anesthesia, you are not likely to be on a dosing schedule.


What happens if I overdose?


An overdose of rocuronium is unlikely to occur since the medication is given by a doctor. Your vital signs will be closely watched while you are under anesthesia to make sure the medication is not causing any harmful effects.


What should I avoid after receiving rocuronium?


Follow your doctor's instructions about any restrictions on food, beverages, or activity after you recover from anesthesia.


Rocuronium side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Tell your caregivers right away if you have any of these serious side effects:

  • fast or uneven heart rate;




  • noisy breathing, feeling short of breath;




  • ongoing muscle weakness; or




  • inability to move your muscles.



Less serious side effects may include:



  • nausea, vomiting;




  • swelling or discomfort where the medicine was injected;




  • feeling sleepy or light-headed; or




  • mild itching or skin rash.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


Rocuronium Dosing Information


Usual Adult Dose for Anesthesia:

Tracheal intubation: Recommended initial dose is 0.6 mg/kg.

Rapid sequence intubation: 0.6 to 1.2 mg/kg.

Maintenance doses: Guided by response to prior dose, not administered until recovery is evident.

Continuous infusion: Initial rate of 10 to 12 mcg/kg/min. Start only after early evidence of spontaneous recovery from an intubating dose.


What other drugs will affect rocuronium?


Before receiving rocuronium, tell your doctor if you are using any of the following drugs:



  • lithium (Eskalith, Lithobid);




  • procainamide (Procan, Procanbid, Pronestyl);




  • seizure medication;




  • an antacid or mineral supplement that contains magnesium;




  • steroids such as prednisone, fluticasone (Advair), mometasone (Asmanex, Nasonex), dexamethasone (Decadron, Hexadrol) and others;




  • a tetracycline antibiotic such as Brodspec, Panmycin, Sumycin, Tetracap, demeclocycline (Declomycin), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), or minocycline (Dynacin, Minocin, Solodyn, Vectrin); or




  • an antibiotic such as amikacin (Amikin), bacitracin (Baci-IM), gentamicin (Garamycin), kanamycin (Kantrex), neomycin (Mycifradin, Neo-Fradin, Neo-Tab), netilmicin (Netromycin), polymyxin (Colistin), colistimethate (Coly-Mycin), streptomycin, tobramycin (Nebcin, Tobi), or vancomycin (Vancocin, Vancoled).



This list is not complete and there may be other drugs that can interact with rocuronium. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More rocuronium resources


  • Rocuronium Side Effects (in more detail)
  • Rocuronium Dosage
  • Rocuronium Use in Pregnancy & Breastfeeding
  • Rocuronium Drug Interactions
  • Rocuronium Support Group
  • 0 Reviews for Rocuronium - Add your own review/rating


  • Rocuronium MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rocuronium Prescribing Information (FDA)

  • Rocuronium Bromide Monograph (AHFS DI)

  • Zemuron Prescribing Information (FDA)



Compare rocuronium with other medications


  • Anesthesia


Where can I get more information?


  • Your doctor or pharmacist can provide more information about rocuronium.

See also: rocuronium side effects (in more detail)


Tuesday, 25 May 2010

Dilox




Dilox may be available in the countries listed below.


Ingredient matches for Dilox



Celecoxib

Celecoxib is reported as an ingredient of Dilox in the following countries:


  • Colombia

Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Dilox in the following countries:


  • Chile

International Drug Name Search

Indorem




Indorem may be available in the countries listed below.


Ingredient matches for Indorem



Indometacin

Indometacin is reported as an ingredient of Indorem in the following countries:


  • Cyprus

  • Kenya

  • Malta

  • Oman

  • Sudan

  • Zimbabwe

International Drug Name Search

Chirocaina




Chirocaina may be available in the countries listed below.


Ingredient matches for Chirocaina



Levobupivacaine

Levobupivacaine hydrochloride (a derivative of Levobupivacaine) is reported as an ingredient of Chirocaina in the following countries:


  • Chile

  • Venezuela

International Drug Name Search

Monday, 24 May 2010

Dimetapp Decongestant Plus Cough Infant Drops


Pronunciation: sue-do-eh-FED-rin/dex-troe-meth-OR-fan
Generic Name: Pseudoephedrine/Dextromethorphan
Brand Name: Examples include Dimetapp Decongestant Plus Cough Infant Drops and Pedia Relief Infant


Dimetapp Decongestant Plus Cough Infant Drops is used for:

Relieving congestion and cough due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.


Dimetapp Decongestant Plus Cough Infant Drops is a decongestant and cough suppressant combination. It works by constricting blood vessels and reducing swelling in the nasal passages, which helps you to breathe more easily. The cough suppressant works in the brain to help decrease the cough reflex.


Do NOT use Dimetapp Decongestant Plus Cough Infant Drops if:


  • you are allergic to any ingredient in Dimetapp Decongestant Plus Cough Infant Drops

  • you have severe high blood pressure, rapid heartbeat, or other severe heart problems (eg, heart blood vessel disease)

  • you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dimetapp Decongestant Plus Cough Infant Drops:


Some medical conditions may interact with Dimetapp Decongestant Plus Cough Infant Drops. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, plan to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of glaucoma, an enlarged prostate gland or other prostate problems, heart problems, diabetes, high blood pressure, blood vessel problems, adrenal gland problems, an overactive thyroid, seizures, or stroke

  • if you have chronic cough, chronic obstructive pulmonary disease (COPD), or other lung problems (eg, asthma, chronic bronchitis, emphysema), or if your cough produces large amounts of mucus

Some MEDICINES MAY INTERACT with Dimetapp Decongestant Plus Cough Infant Drops. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Beta-blockers (eg, propranolol), COMT inhibitors (eg, tolcapone), furazolidone, indomethacin, MAO inhibitors (eg, phenelzine), or tricyclic antidepressants (eg, amitriptyline) because the risk of side effects from Dimetapp Decongestant Plus Cough Infant Drops may be increased

  • Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased

  • Bromocriptine because the risk of side effects may be increased by Dimetapp Decongestant Plus Cough Infant Drops

  • Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Dimetapp Decongestant Plus Cough Infant Drops

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dimetapp Decongestant Plus Cough Infant Drops may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dimetapp Decongestant Plus Cough Infant Drops:


Use Dimetapp Decongestant Plus Cough Infant Drops as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Dimetapp Decongestant Plus Cough Infant Drops may be taken with or without food.

  • Use the dropper that comes with Dimetapp Decongestant Plus Cough Infant Drops to measure your dose. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • If you miss a dose of Dimetapp Decongestant Plus Cough Infant Drops, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dimetapp Decongestant Plus Cough Infant Drops.



Important safety information:


  • Dimetapp Decongestant Plus Cough Infant Drops may cause dizziness or drowsiness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Dimetapp Decongestant Plus Cough Infant Drops. Using Dimetapp Decongestant Plus Cough Infant Drops alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • Do not take appetite suppressants while you are taking Dimetapp Decongestant Plus Cough Infant Drops without checking with your doctor.

  • Dimetapp Decongestant Plus Cough Infant Drops contains pseudoephedrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains pseudoephedrine. If it does or if you are uncertain, contact your doctor or pharmacist.

  • Do NOT exceed the recommended dose or take Dimetapp Decongestant Plus Cough Infant Drops for longer than prescribed without checking with your doctor.

  • If your symptoms do not improve within 5 to 7 days or if they become worse, check with your doctor.

  • Dimetapp Decongestant Plus Cough Infant Drops may interfere with certain lab test results. Make sure that all of your doctors and lab personnel know that you are taking Dimetapp Decongestant Plus Cough Infant Drops.

  • Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Dimetapp Decongestant Plus Cough Infant Drops.

  • Use Dimetapp Decongestant Plus Cough Infant Drops with caution in the ELDERLY because they may be more sensitive to its effects.

  • Caution is advised when using Dimetapp Decongestant Plus Cough Infant Drops in CHILDREN because they may be more sensitive to its effects.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Dimetapp Decongestant Plus Cough Infant Drops, discuss with your doctor the benefits and risks of using Dimetapp Decongestant Plus Cough Infant Drops during pregnancy. It is unknown if Dimetapp Decongestant Plus Cough Infant Drops is excreted in breast milk. Do not breast-feed while taking Dimetapp Decongestant Plus Cough Infant Drops.


Possible side effects of Dimetapp Decongestant Plus Cough Infant Drops:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dizziness; excitability; headache; nausea; nervousness or anxiety; trouble sleeping; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.


Proper storage of Dimetapp Decongestant Plus Cough Infant Drops:

Store Dimetapp Decongestant Plus Cough Infant Drops at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dimetapp Decongestant Plus Cough Infant Drops out of the reach of children and away from pets.


General information:


  • If you have any questions about Dimetapp Decongestant Plus Cough Infant Drops, please talk with your doctor, pharmacist, or other health care provider.

  • Dimetapp Decongestant Plus Cough Infant Drops is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dimetapp Decongestant Plus Cough Infant Drops. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dimetapp Decongestant Plus Cough Infant resources


  • Dimetapp Decongestant Plus Cough Infant Use in Pregnancy & Breastfeeding
  • Dimetapp Decongestant Plus Cough Infant Drug Interactions
  • Dimetapp Decongestant Plus Cough Infant Support Group
  • 0 Reviews for Dimetapp Decongestant Plus Cough Infant - Add your own review/rating


Compare Dimetapp Decongestant Plus Cough Infant with other medications


  • Cough and Nasal Congestion

Sunday, 23 May 2010

Ripin




Ripin may be available in the countries listed below.


Ingredient matches for Ripin



Rifampicin

Rifampicin is reported as an ingredient of Ripin in the following countries:


  • Taiwan

International Drug Name Search

Saturday, 22 May 2010

Prometazina Cloridrato Zeta




Prometazina Cloridrato Zeta may be available in the countries listed below.


Ingredient matches for Prometazina Cloridrato Zeta



Promethazine

Promethazine is reported as an ingredient of Prometazina Cloridrato Zeta in the following countries:


  • Italy

International Drug Name Search

Wednesday, 19 May 2010

Blokium Diu




Blokium Diu may be available in the countries listed below.


Ingredient matches for Blokium Diu



Atenolol

Atenolol is reported as an ingredient of Blokium Diu in the following countries:


  • Hungary

  • Spain

Chlortalidone

Chlortalidone is reported as an ingredient of Blokium Diu in the following countries:


  • Hungary

  • Spain

International Drug Name Search

Fenitoina Rubio




Fenitoina Rubio may be available in the countries listed below.


Ingredient matches for Fenitoina Rubio



Phenytoin

Phenytoin sodium salt (a derivative of Phenytoin) is reported as an ingredient of Fenitoina Rubio in the following countries:


  • Spain

International Drug Name Search

Sunday, 16 May 2010

Mexazolam




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0031868-18-5

Chemical Formula

C18-H16-Cl2-N2-O2

Molecular Weight

363

Therapeutic Categories

Anxiolytic agent

Sedative agent

Benzodiazepine derivative

Chemical Name

Oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one, 10-chloro-11b-(2-chlorophenyl)-2,3,7,11b-tetrahydro-3-methyl-

Foreign Names

  • Mexazolamum (Latin)
  • Mexazolam (German)
  • Mexazolam (French)
  • Mexazolam (Spanish)

Generic Names

  • Mexazolam (OS: JAN)
  • CS 386 (IS: Sankyo)

Brand Names

  • Melex
    Daiichi Sankyo, Japan


  • Sedoxil
    Bial, Portugal; Bial - Portela, Malta

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

RVPaque


Generic Name: zinc oxide topical (ZINK OX ide)

Brand Names: ARC, Balmex, Boudreaux Butt Paste, Caldesene, Calmol-4 Suppository, Critic-Aid Skin Paste, Delazinc, Dermagran BC, Desitin, Desitin Maximum Strength Original, Desitin Rapid Relief Creamy, Diaper Rash Ointment, Diaper Relief, Dr. Smith's Diaper, Flanders Buttocks Ointment, Geri-Protect, Medi-Paste, PeriGuard, Pinxav, Rash Relief, RVPaque, Seniortopix Healix, Soothe & Cool Skin Paste, Sportz Block Dark, Sportz Block Light, Sportz Block Medium, Triple Paste, Tronolane Suppositories, Unna-Flex Elastic Unna Boot 3 inch, Unna-Flex Elastic Unna Boot 4 inch, Znlin


What is RVPaque (zinc oxide topical)?

Zinc oxide is a mineral.


Zinc oxide topical (for the skin) is used to treat diaper rash, minor burns, severely chapped skin, or other minor skin irritations.


Zinc oxide rectal suppositories are used to treat itching, burning, irritation, and other rectal discomfort caused by hemorrhoids or painful bowel movements.


Zinc oxide topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about RVPaque (zinc oxide topical)?


You should not use this medication if you are allergic to zinc, dimethicone, lanolin, cod liver oil, petroleum jelly, parabens, mineral oil, or wax.

Zinc oxide topical will not treat a bacterial or fungal infection. Call your doctor if you have any signs of infection such as redness and warmth or oozing skin lesions.


Keep the diaper area clean and dry to prevent worsening of skin rash. Change wet diapers as soon as possible. Allow the skin to dry thoroughly before putting on a fresh diaper.


Stop using this medication and call your doctor if your condition does not improve within 7 days of treatment. Avoid getting this medication in your mouth or eyes. If this does happen, rinse with water right away. Do not use zinc oxide topical on deep skin wounds or severe burns. Get medical attention for more severe skin irritation or injury.

Avoid using other medications on the areas you treat with zinc oxide unless you doctor tells you to.


What should I discuss with my health care provider before using RVPaque (zinc oxide topical)?


You should not use this medication if you are allergic to zinc, dimethicone, lanolin, cod liver oil, petroleum jelly, parabens, mineral oil, or wax.

Zinc oxide topical will not treat a bacterial or fungal infection. Call your doctor if you have any signs of infection such as redness and warmth or oozing skin lesions.


It is not known whether zinc oxide topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether zinc oxide topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without medical advice if you are breast-feeding a baby.

How should I use RVPaque (zinc oxide topical)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Apply enough of this medication to cover the entire area to be treated. Zinc oxide often leaves a thin white residue that may not be entirely rubbed in.


To treat chapped skin, minor burn wounds, or other skin irritations, use the medication as often as needed. Apply a thin layer to the affected area and rub in gently.


To treat diaper rash, use this medication each time the diaper is changed. It is especially important to apply the medication at bedtime or whenever there will be a long period of time between diaper changes.


Keep the diaper area clean and dry to prevent worsening of skin rash. Change wet diapers as soon as possible. Allow the skin to dry thoroughly before putting on a fresh diaper.


When using the powder form of this medicine, pour the powder slowly to avoid a large puff into the air. Do not allow a baby to handle a powder bottle during use. Always close the lid after using the powder.

Zinc oxide rectal suppositories come with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


Wash your hands before and after inserting a rectal suppository.

Try to empty your bowel and bladder just before using the suppository. Cleanse and dry your rectal area thoroughly.


Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


For best results, stay lying down after inserting the suppository and hold it in your rectum for a few minutes. The suppository will melt quickly once inserted and you should feel little or no discomfort while holding it in.


Stop using this medication and call your doctor if your condition does not improve within 7 days of treatment. Store at room temperature away from moisture and heat. Keep the tube cap tightly closed when not in use. You may store zinc oxide rectal suppositories in a refrigerator to prevent melting.

What happens if I miss a dose?


Since zinc oxide is used on an as needed basis, you are not likely to miss a dose. Using extra zinc oxide to make up a missed dose will not make the medication more effective.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using RVPaque (zinc oxide topical)?


Avoid getting this medication in your mouth or eyes. If this does happen, rinse with water right away. Do not use zinc oxide topical on deep skin wounds or severe burns. Get medical attention for more severe skin irritation or injury.

RVPaque (zinc oxide topical) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using zinc oxide rectal suppositories if you have rectal bleeding or continued pain.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect RVPaque (zinc oxide topical)?


Avoid applying other skin medications on the same treatment area with zinc oxide, unless your doctor has told you to.


There may be other drugs that can interact with zinc oxide topical or rectal suppositories. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More RVPaque resources


  • RVPaque Side Effects (in more detail)
  • RVPaque Use in Pregnancy & Breastfeeding
  • RVPaque Support Group
  • 0 Reviews for RVPaque - Add your own review/rating


  • Arcalyst Monograph (AHFS DI)

  • Caldesene Topical Advanced Consumer (Micromedex) - Includes Dosage Information

  • Desitin Cream MedFacts Consumer Leaflet (Wolters Kluwer)



Compare RVPaque with other medications


  • Anal Itching
  • Dermatologic Lesion


Where can I get more information?


  • Your pharmacist can provide more information about zinc oxide topical.

See also: RVPaque side effects (in more detail)